Latest news
AstraZeneca receives CDSCO approval of additional indication for trastuzumab deruxtecan - BioSpectrum IndiaBioSpectrum India · Sun, 09 Aug 2026 17:43:21 GMTAstraZeneca Pharma India receives CDSCO approval for HER2-positive stage II or III early breast cancer treatment - BioSpectrum IndiaBioSpectrum India · Tue, 28 Jul 2026 07:00:00 GMT